Stock 600557 JIANGSU KANION PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Kanion Pharmaceutical Co.,Ltd.

Equities

600557

CNE000001CL7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 05/07/2024 am IST 		5-day change 1st Jan Change
15.88 CNY +3.93% Intraday chart for Jiangsu Kanion Pharmaceutical Co.,Ltd. +1.15% -22.61%
25/04 Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025. CI
12/04 Jiangsu Kanion Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The Company's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The Company distributes its products mainly within domestic markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
44.7 %
1,451 33.4 % 2,174 44.7 % +49.80%
Capsules
18.2 %
873 20.1 % 888 18.2 % +1.70%
Oral Liquid
17.8 %
1,122 25.8 % 864 17.8 % -22.99%
Tablets and Pills
7.2 %
338 7.8 % 351 7.2 % +3.68%
Granules and Granules
6.7 %
281 6.5 % 328 6.7 % +16.82%
Patch
4.3 %
226 5.2 % 211 4.3 % -6.55%
Other
0.6 %
27 0.6 % 28 0.6 % +2.98%
Gel
0.5 %
32 0.7 % 24 0.5 % -26.07%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
4,351 100.0 % 4,868 100.0 % +11.88%

Managers

Managers TitleAgeSince
Yong Chun Yang CEO
 Chief Executive Officer 51 01/97/01
Suo Cheng Jiang DFI
 Director of Finance/CFO 47 01/00/01
Wei Xiao CHM
 Chairman 65 01/00/01
Mei Ling Jiang BRD
 Director/Board Member 44 01/06/01
Di Wu BRD
 Director/Board Member 42 01/12/01
Xue Bin Chen BRD
 Director/Board Member 39 01/22/01
Hai Xin Gao BRD
 Director/Board Member 36 01/14/01
Lin Jiang BRD
 Director/Board Member 42 01/21/01
Zhen Zhong Wang BRD
 Director/Board Member 56 01/93/01
Yan Xi Chen IRC
 Investor Relations Contact 37 01/09/01

Members of the board

Members of the board TitleAgeSince
Wei Xiao CHM
 Chairman 65 01/00/01
Kai Xian Chen BRD
 Director/Board Member 78 27/19/27
Yong Chun Yang CEO
 Chief Executive Officer 51 01/97/01
Zhen Zhong Wang BRD
 Director/Board Member 56 01/93/01
Shi Hua Yin CHM
 Chairman 49 01/17/01
Chang Qin Hu BRD
 Director/Board Member 49 01/93/01
Hai Xin Gao BRD
 Director/Board Member 36 01/14/01
Xue Bin Chen BRD
 Director/Board Member 39 01/22/01
Jin Ao Duan BRD
 Director/Board Member 68 26/23/26
Di Wu BRD
 Director/Board Member 42 01/12/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 588,898,052 337,103,706 ( 57.24 %) 7,100,600 ( 1.206 %) 57.24 %

Shareholders

NameEquities%Valuation
Jiangsu Kanion Group Co., Ltd.
30.56 %
176,173,467 30.56 % 422 M ¥
Lianyungang Kangbeier Medical Equipment Co. Ltd.
5.529 %
31,870,567 5.529 % 76 M ¥
China Investment Corp. (Investment Management)
3.103 %
17,886,480 3.103 % 43 M ¥
Wei Xiao
2.950 %
17,003,232 2.950 % 41 M ¥
Shanghai Silver Leaf Investment Co., Ltd.
2.072 %
11,945,196 2.072 % 29 M ¥
China Asset Management Co., Ltd.
1.964 %
11,322,001 1.964 % 27 M ¥
CHINA MERCHANTS BANK CO., LTD.
1.489 %
8,580,753 1.489 % 21 M ¥
Essence Fund Co., Ltd.
1.302 %
7,506,653 1.302 % 18 M ¥
Rongtong Fund Management Co., Ltd.
1.273 %
7,340,600 1.273 % 18 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.9617 %
5,543,660 0.9617 % 13 M ¥
NameEquities%Valuation
Yong Chun Yang
2.571 %
210,000 2.571 % 502 969 ¥
Zhen Zhong Wang
2.571 %
210,000 2.571 % 502 969 ¥
Chuan Lei Wang
1.714 %
140,000 1.714 % 335 313 ¥
Yu Pan
1.714 %
140,000 1.714 % 335 313 ¥
Quan Liu
1.714 %
140,000 1.714 % 335 313 ¥
Hai Xin Gao
1.714 %
140,000 1.714 % 335 313 ¥
Yun Wu
1.285 %
105,000 1.285 % 251 484 ¥

Company contact information

Jiangsu Kanion Pharmaceutical Co., Ltd.

58 Kangyuan Road Jiangning Industrial town

222000, Lianyungang

+86 518 8552 1948

http://www.kanion.com
address Jiangsu Kanion Pharmaceutical Co.,Ltd.(600557)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Jiangsu Kanion Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
15.88 CNY
Average target price
24.84 CNY
Spread / Average Target
+56.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU KANION PHARMACEUTICAL CO.,LTD. Stock Jiangsu Kanion Pharmaceutical Co.,Ltd.
-22.61% 1.27B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.89% 823B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.52% 627B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.55% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.99% 320B
ABBVIE INC. Stock AbbVie Inc.
+7.92% 295B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.74% 239B
NOVARTIS AG Stock Novartis AG
+13.83% 220B
ROCHE HOLDING AG Stock Roche Holding AG
-0.49% 219B
AMGEN INC. Stock Amgen Inc.
+7.94% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600557 Stock
  4. Company Jiangsu Kanion Pharmaceutical Co.,Ltd.